Drug: ERBITUX Injury: Malignant neoplasm progression Quarter: 2016Q3
Total Records: 9 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
124281922 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 71.00 YR | M | 0 | 20160819 | DE |
124761472 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 63.00 YR | F | 0 | 20160705 | DE |
125837661 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 50.00 YR | M | 0 | 20160722 | ES |
126066222 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 60.00 YR | M | 0 | 20160801 | DE |
126154251 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 0.00 | 0 | 20160802 | DE | |
127078072 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 52.00 YR | M | 67 KG | 20160907 | DE |
127372601 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 0.00 | F | 0 | 20160913 | US |
127669791 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 87.00 YR | M | 0 | 20160921 | US |
128000911 | ERBITUX | Malignant neoplasm progression | ELI LILLY AND CO | 58.00 YR | F | 0 | 20160930 | DE |
Total Records: 9 Number of Pages: 1